U.S. drugmaker Pfizer Inc is working on its next move in a potential $100 billion bid battle for Britain's AstraZeneca Plc after having a two offers rejected, as deal-making grips the healthcare industry.Pfizer said on Monday it made a 58.8 billion pounds ($98.9 billion) bid approach to AstraZeneca in January and had contacted its British rival again on April 26 seeking further discussions about a takeover.AstraZeneca shares jumped 15 percent in early trade.The cash and shares takeover, if it happens, would be the biggest-ever foreign takeover of a British company and one of the largest-ever pharmaceuticals deals.
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. Shares of AZN fell by 0.51% or $-0.35/share to $68.66. In the past year, the shares have traded as low as $46.87 and as high as $70.71. On average, 2448110 shares of AZN exchange hands on a given day and today's volume is recorded at 2093592.
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. Shares of PFE traded higher by 0.13% or $0.04/share to $30.75. In the past year, the shares have traded as low as $27.12 and as high as $32.96. On average, 28547900 shares of PFE exchange hands on a given day and today's volume is recorded at 18670130.
Source
